In this episode, Candice Taguibao chats with Dr. Caroline Figueroa, Dr. Gina Ogilvie, and Dr. Roopan Gill about digital health, equity, and innovation.

Mentioned in this episode:

About the speakers:

Candice Taguibao is the digital health research manager at the Women’s Health Research Institute. She is interested in the ways that digital technologies can be used responsibly to improve health outcomes and health system processes. Candice has a background in public health and has previously worked in academic and health tech spaces. Candice completed her B.Sc. from McGill University and her MPH at the Yale School of Public Health.

Dr. Roopan Gill is an obstetrician gynecologist with expertise in family planning and abortion care. She completed her training in Canada and holds a Masters in Public Health in Global Health from Harvard T.H. Chan School of Public Health. She has worked as an emergency obstetrician gynecologist in Nigeria and Yemen with MSF and most recently as their Women's Health Advisor supporting projects in countries such as Malawi, Chad and Pakistan.

She has previously worked with the World Health Organization (WHO) providing technical expertise to its Department of Sexual and Reproductive Health Research. She played a pivotal role in the WHO Essential Medicines List application to bring Mifepristone and the combination of Mifepristone and Misoprostol to its core list and was on the Evidence Review team for both their Medical Management of Abortion guidance and the recently launched Abortion Care guidelines. Roopan has published in peer-reviewed journals focussing on better understanding the challenges and needs of women and girls accessing reproductive and sexual healthcare needs. Most recently she was featured in Forbes as one of seven female founders committed to inclusivity and accessibility.

Caroline Figueroa, MD Ph.D., is a Psychiatry Resident at the University Medical Centre in Utrecht, and an affiliate researcher at UC Berkeley School of Social Welfare. She obtained her MD degree and Ph.D. degree at the University of Amsterdam in the Netherlands. Her Ph.D. research took place at the University of Amsterdam and at the University of Oxford, where she studied cognitive and neurobiological vulnerability factors for recurrence of depression in patients remitted from Major Depressive Disorder. Current research interest is on digital interventions for depression, with an emphasis on developing cutting-edge innovations that tailor to the needs of underserved
populations.

Gina Ogilvie, MD MSc FCFP DrPH, is a Tier 1 Canada Research Chair in Global Control of HPV related diseases and prevention, Professor at the University of British Columbia in the School of Population and Public Health, and Associate Director of the Women’s Health Research Institute.

Dr. Ogilvie is currently principal investigator on over $13-million in research grants and she has received funding from PHAC, CIHR, Michael Smith Foundation for Health Research, Canadian Foundation for Innovation and private foundations including BC Women’s Hospital Foundation among others.

Her research is focused on both the public health and clinical aspects of reproductive health, sexually transmitted infections, HPV screening and the HPV vaccine, and her findings have been highly influential in setting and directing health policy both in Canada and globally.

Episode 2: Fighting misinformation online